Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

Sergei I. Grivennikov(University of California, San Diego), Kepeng Wang(University of California, San Diego), Daniel Mucida(La Jolla Institute for Immunology), Charles A. Stewart(Center for Cancer Research), Bernd Schnabl(University of California, San Diego), Dominik Jauch(University of California, San Diego), Koji Taniguchi(University of California, San Diego), Guann‐Yi Yu(University of California, San Diego), Christoph H. Österreicher(University of California, San Diego), Kenneth E. Hung(Tufts Medical Center), Christian Datz(Paracelsus Medical University), Ying Feng(University of Michigan–Ann Arbor), Eric R. Fearon(University of Michigan–Ann Arbor), Mohamed Oukka, Lino Tessarollo(Cancer Genetics (United States)), Vincenzo Coppola(The Ohio State University Wexner Medical Center), Felix Yarovinsky(The University of Texas Southwestern Medical Center), Hilde Cheroutre(La Jolla Institute for Immunology), Lars Eckmann(University of California, San Diego), Giorgio Trinchieri(Center for Cancer Research), Michael Karin(University of California, San Diego)
Nature
October 2, 2012
Cited by 1,303Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis